Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMRYQBE)

Drug Name

AS-1406 Drug Info

Synonyms

Theranase; HuHMFG1-huRNase; Targeted apoptosis (RNase), Antisoma

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Terminated	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Ribonuclease (RNase)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
NTO-1151	DMRYLBW	Cervical cancer	2C77.0	Phase 2	[3]
Ranpirnase	DMM15RI	Lung cancer	2C25.0	Phase 2	[4]
MazF gene therapy	DMSZ8HT	Human immunodeficiency virus-1 infection	1C62	Phase 1	[5]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

References

1	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800012949)
2	WO patent application no. 2005,0657,17, Liquid formulations of antibody conjugates.
3	Clinical pipeline report, company report or official report of Nanotherapeutics.
4	Ranpirnase (Onconase), a cytotoxic amphibian ribonuclease, manipulates tumour physiological parameters as a selective killer and a potential enhancer for chemotherapy and radiation in cancer therapy.Expert Opin Biol Ther. 2008 Jun;8(6):813-27.
5	Clinical pipeline report, company report or official report of Takara Bio.